For a better experience, click the Compatibility Mode icon above to turn off Compatibility Mode, which is only for viewing older websites.

Pfizer Had Clues Its Blockbuster Drug Could Prevent Alzheimer's. Why Didn't It Tell the World?

The Washington Post

June 4, 2019

Robert I. Field, PhD, JD, a professor in the Dornsife School of Public Health and Kline School of Law, was quoted in a June 4 Washington Post article about a team of Pfizer researchers who found its rheumatoid arthritis therapy drug could also potentially reduce the risk of Alzheimer’s disease. Field explained the procedures a company must go through to receive regulatory approval to use a drug for a completely different disease. View Story